UK oncology information system market was $150 million in 2018 and is estimated to grow at a CAGR of 9.6% over the forecast period to reach $280 million in 2025. Major factors that augment the growth of the market include a significant prevalence of cancer coupled with the increased penetration of digitalization in the healthcare sector. The increasing prevalence of cancer in the country is one of the key factors which is expected to promote the demand for advanced systems, such as oncology information systems, that can manage patient treatment schedules, treatment plans, treatment delivery, treatment summaries, and results. Well established healthcare infrastructure is also one of the key reasons which are expected to promote the implementation of oncology information system in healthcare facilities, thereby, driving the growth of the market in the near future.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-oncology-information-system-market
The UK Oncology Information System market is segmented on the basis of oncology type and end-user. On the basis of oncology type, the market is segmented into medical oncology, radiation oncology, and surgical oncology. Medical oncology segment dominated the market in 2018 and is further estimated to continue the same trend over the forecast period. Medical oncology includes immunotherapy, chemotherapy, targeted therapy, and hormonal therapy. With the increasing number of cancer cases, the use of these therapies increases, which in turn, drives the segmental growth of the market.
In addition, the key players such as Elekta AB, Verian Medical Systems, Inc., and Cerner Corp., contribute significantly to the segmental growth of the market. For instance, MOSAIQ Medical Oncology system offered by Elekta AB efficiently manage all the chemotherapy program, ranging from diagnosis to treatment post-follow-up. Additionally, it manages medical record of patient for multiple treatment types and reduces errors and inefficiencies. Furthermore, based on the end-user, the market is classified into hospitals and clinics, diagnostic centers, and others.
The UK Oncology Information System market is characterized with the presence of various players operating in the market. Some of the prominent players that contribute significantly in the market include Elekta AB, Cerner Corp., Koninklijke Philips N.V., Verian Medical Systems, Inc., Mckesson Corp., IBM Corp. and others. These players operate in very highly competitive environment and thus adopts various strategies to stay competitive in the market. Mergers and acquisitions, new product launch, geographical expansion, manufacturing capability expansion are some of the majorly adopted strategies by these market players.
UK Oncology Information System Market Segmentation
By Oncology Type
- Medical Oncology
- Surgical Oncology
- Radiation Oncology
By End-User
- Hospitals & Clinics
- Diagnostic Centers
- Others (Research Institute)
A full report of UK Oncology Information System Market available @ https://www.omrglobal.com/industry-reports/uk-oncology-information-system-market
Company Profiles
- Accuray, Inc.
- AdvancedMD, Inc.
- Allscripts Healthcare Solutions, Inc.
- Bizmatics, Inc.
- Carevive Systems, Inc.
- Cerner Corp.
- Elekta AB
- Epic Systems Corp.
- Hoffmann-La Roche AG
- IBM Corp.
- Koninklijke Philips N.V.
- Mckesson Corp.
- Medical Information Technology, Inc.
- RaySearch Laboratories AB
- Siemens AG
- Syapse Inc.
- Varian Medical Systems, Inc.
